6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G
about
Determinants of clinician knowledge on aging and HIV/AIDS: a survey of practitioners and policy makers in Kampala District, UgandaPrevention of vertical transmission of HIV-1 in resource-limited settingsAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionInterventions for preventing late postnatal mother-to-child transmission of HIVAntiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionReduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmissionTwo-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Côte d'IvoireHaematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trialChildren who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysisGlobal impact of human immunodeficiency virus and AIDS.Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.A coarsened multinomial regression model for perinatal mother to child transmission of HIV.Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: part III: placental malaria, maternal health, and public health.Improving outcomes in infants of HIV-infected women in a developing country settingHIV: mother-to-child transmissionHIV prevention is not enough: child survival in the context of prevention of mother to child HIV transmissionPrevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South AfricaMetabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infantsA human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line.What can we do to reduce mother to child transmission of HIV?Improving child health: the role of research.Appropriate feeding methods for infants of HIV infected mothers in sub-Saharan AfricaHIV: prevention of mother-to-child transmission.Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.Interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection.Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast.Efficacy of a less-sensitive enzyme immunoassay (3A11-LS) for early diagnosis of human immunodeficiency virus Type 1 infection in infantsMaternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaquesCurrent treatment options to prevent perinatal transmission of HIV.Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?Antiretroviral treatments to reduce mother-to-child transmission of HIV.Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251.Transmission of HIV in the dental clinic and elsewhere.Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.Perinatal HIV transmission: developing country considerations.Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT
P2860
Q21133665-57AA5BA2-21D8-4DB6-AA28-F487E7AA8EA0Q22241479-406D5CDD-FD19-434F-9485-E74168FFB091Q24235500-FC8CFB17-9AF0-4FDF-A0B7-D5FF95823049Q24241793-E4C1717D-9A79-4FF4-A869-5DBBFC00DB9EQ24243146-0CD42532-DFBE-486F-8011-F35800820448Q28362322-E71F0B06-B012-476C-870B-498000CCA849Q28469112-D9919131-5B0E-4491-9F35-570381EE980DQ28469195-490E3A71-BA31-479C-9FE9-8BEA5527DE83Q28731813-AC0346D8-FDDD-44FA-AA3D-38D618B2D53FQ30328098-47F6D335-CDE6-4BF3-9794-326A443BDF63Q33284135-8A33B609-988F-4B66-B592-D5111969A697Q33294899-4EDF1C2B-40E7-4EA0-B97F-B213ABE9FE88Q33320539-47D4AB62-25B4-4666-9F1B-F9F3210F947AQ33336235-8964A2D6-1A7E-4972-A7B9-F1A861861943Q33351797-2511AD9B-D5F6-433A-940F-35D3E4D0814FQ33380234-59BE09E4-564D-4C68-9907-CEA6F0604616Q33384449-486E9A9C-B1F3-4551-98E9-706E4D91510DQ33446714-46D7E3A4-22A2-4F48-BB29-AA0122D1AC3DQ33552646-5F8776F3-305D-4E78-8F4F-9D58CE19FAD6Q33622040-E0E2E082-EF3B-4B58-A586-89D7CD09F0B3Q33747993-967DF0EA-E602-4CB0-A4FA-1BF3D61111D5Q33796739-B7525605-7642-49A0-9291-A394F23C1827Q33808840-49CDDEA8-59B9-4DCD-849D-F7D3FA1D48F2Q33810830-2E672DC4-ED96-4FD5-9535-8A784E458E3EQ33817221-82F3D68F-D3B2-4054-B008-6FA60FCFC741Q33866493-280381D2-5DE1-483F-B276-C82F675765ABQ33897042-4EF8EF3B-F39B-49F1-BAC5-DD6439127231Q33906773-ACC6A7F1-1AEA-44CD-808D-718283088CFAQ33972240-F928680B-C20C-462B-93F7-8ABF09866AEEQ33999828-31907611-9EBD-489C-B167-562A015AEF9EQ34151052-38A1B77A-658A-4F9B-BDB1-74CCA5E63AFBQ34182238-C43F82C5-EB67-4BEB-9CE2-6344C9C1B927Q34313201-7A9F3B71-7ECE-4857-90B6-5BFA73E5E37CQ34394712-0AF723C5-9F54-4C87-B0E4-A21EFE6E8EB6Q34461381-371610BC-72C4-4E90-84F4-851F41C2A044Q34462107-153D57B5-2536-461A-9A8F-28A09B0B595DQ34775216-D2406474-A538-45B3-8752-7B01EB2F2104Q35031969-93AC7D49-F619-4D31-9540-833D87236F15Q35046412-B070109A-C7D5-4CF2-AE05-544AD823F473Q35079468-3425840E-BD8C-492F-9C41-0EC21C2B5CB2
P2860
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@en
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@nl
type
label
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@en
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@nl
prefLabel
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@en
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@nl
P2093
P50
P921
P1433
P1476
6-month efficacy, tolerance, a ...... icentre trial. DITRAME Study G
@en
P2093
C Welffens-Ekra
L Mandelbrot
O Ky-Zerbo
O Manigart
P304
P356
10.1016/S0140-6736(98)11046-2
P407
P577
1999-03-01T00:00:00Z